Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats

被引:0
|
作者
Wang, X
Zhong, YX
Zhang, ZY
Lu, J
Lan, M
Miao, JY
Guo, XG
Shi, YQ
Zhao, YQ
Ding, J
Wu, KC
Pan, BR
Fan, DM [1 ]
机构
[1] Military Med Univ 4, Xijing Hosp, Inst Digest Dis, Shaanxi 710033, Peoples R China
[2] Military Med Univ 4, Tangdu Hosp, Emergency Dept, Shaanxi 710038, Peoples R China
[3] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Oncol Ctr, Xian 710032, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats. METHODS: Rats with cirrhosis induced by carbon tetrachloride were randomly divided into two groups, one( n = 13) receiving 0. 5 mg . kg(-1) per day of N-G-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, for 10 days, whereas the other group ( n = 13) and control ( n = 10) rats were administrated the same volume of 9 g . L-1 saline. Half gastric emptying time and 2 h residual rate were measured by SPECT, using (99m) Tc-DTPA-labeled barium sulfate as test meal. Gastrointestinal transition time was recorded simultaneously. Serum concentration of nitric oxide ( NO) was determined by the kinetic cadmium reduction and colorimetric methods. Immunolhistochemical SABC method was used to observe the expression and distribution of three types of nitric oxide synthase (NOS) isoforms in the rat gastrointestinal tract. Western blot was used to detect expression of gastrointestinal NOS isoforms. RESULTS: Half gastric emptying time and transgastrointestinal time were significantly prolonged( 124. 0 +/- 26. 4 min; 33.7 +/- 8.9 min;72.1 +/- 15.3 min; P < 0.01), (12.4 +/- 0.5 h; 9.5 +/- 0.3 h; 8.2 +/- 0.8 h; P < 0. 01), 2 h residual rate was raised in cirrhotic rats than in controls and cirrhotic rats treated with L-NAME(54.9 +/- 7.6 %,13.7 +/- 3.2 %, 34.9 +/- 10.3 %, P < 0.01). Serum concentration of NO was significantly increased in cirrhotic rats than in the other groups (8.20 +/- 2.48) mumol . L-1, (5.94 +/- 1.07) mumol . L-1, and control (5.66 +/- 1.60) mumol . L-1, P < 0.01. NOS staining intensities which were mainly located in the gastrointestinal tissues were markedly lower in cirrhotic rats than in the controls and cirrhotic rats after treated with L-NAME. CONCLUSION: Gastrointestinal motility was remarkably inhibited in cirrhotic rats, which could be alleviated by L-NAME. Nitric oxide may play an important role in the inhibition of gastrointestinal motility in cirrhotic rats.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 50 条
  • [31] Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock
    Avontuur, JAM
    Nolthenius, RPT
    Buijk, SLCE
    Kanhai, KJK
    Bruining, HA
    CHEST, 1998, 113 (06) : 1640 - 1646
  • [32] Social isolation stress alters the anxiolytic effect of nitric oxide synthase inhibitor, L-Name
    Wongwildecha, N.
    Soo-ampon, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 51 - 51
  • [33] Effect of nitrates on clotting at the rats with L-NAME introduction
    Kashcheyeu, Y.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S119 - S119
  • [34] Chronic Stress Deteriorated Nitric Oxide Production in Wistar Rats Exposed to a Low Dose of L-NAME
    Bernatova, Iveta
    Kopincova, Jana
    Puzserova, Angelika
    ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2010, 52 (03): : 200 - 205
  • [35] Psychological stress alters the anxiolytic effect of midazolam and nitric oxide synthase inhibitor, L-name
    Wongwitdecha, N
    Soo-ampon, S
    Yoopan, N
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S460 - S460
  • [36] Effect of the Nitric Oxide Synthesis Inhibitor L-NAME on the Isolated Rat Heart after Hypokinesia
    Sungatullina M.I.
    Zaripova R.I.
    Ziyatdinova N.I.
    Yafarova G.G.
    Andrianov V.V.
    Gainutdinov K.L.
    Zefirov T.L.
    Biophysics, 2023, 68 (4) : 612 - 617
  • [37] Nitric oxide bioavailability is also regulated by the cGMP pathway in L-NAME hypertensive cardiomyopathy of rats.
    Ferreira-Melo, S
    Yugar-Toledo, JC
    Souza, WA
    Thomaz, AJ
    Franchini, KG
    Coelho, OR
    de Lucca, I
    Moreno, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P13 - P13
  • [38] Nitric oxide (NO) bioavailability is also regulated by cGMP pathway in L-NAME hypertensive cardiomyopathy in rats.
    Ferreira, SE
    Yugar, JC
    Souza, WA
    Thomaz, AJ
    Franchini, KG
    Coelho, OR
    de Lucca, IM
    Moreno, H
    JOURNAL OF HYPERTENSION, 2004, 22 : S34 - S34
  • [39] EFFECT OF CHRONIC LOW-DOSE L-NAME TREATMENT ON NITRIC OXIDE SYNTHESIS AND ENDOTHELIAL FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS
    Balis, P.
    Puzserova, A.
    Slezak, P.
    Kopincova, J.
    Bernatova, I.
    JOURNAL OF HYPERTENSION, 2010, 28 : E498 - E499
  • [40] The effect of combined systemic administration of morphine and L-name, a nitric oxide synthase inhibitor, on behavioral signs of neuropathic pain in rats
    Ulugol, A
    Aslantas, A
    Karadag, HC
    Bulbul, ED
    Tuncer, A
    Dokmeci, I
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 2002, 30 (03) : 143 - 153